Beneficial effect of LDL-apheresis in refractory nephrotic syndrome

Clinical and Experimental Nephrology

Volumn 18, Issue 2, 2014, Pages 286-290

  Muso, Eri ^a  

^a Kitano Hospital   (Japan)

Author keywords

Cohort study; LDL apheresis; Lipid nephrotoxicity; Nephrotic syndrome; Secondary hyperlipidemia

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 8; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; TUMOR NECROSIS FACTOR ALPHA; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

APHERESIS; DYSLIPIDEMIA; HUMAN; HYPERLIPIDEMIA; KIDNEY TUBULE; LIPOPROTEIN SYNTHESIS; LOW DENSITY LIPOPROTEIN APHERESIS; NEPHROTIC SYNDROME; OXIDATIVE STRESS; REMISSION; REVIEW; THERAPY EFFECT; TREATMENT OUTCOME; URINARY EXCRETION; ADSORPTION; BLOOD; DRUG EFFECTS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; GLOMERULUS; HYPERLIPIDEMIAS; PROCEDURES;

ADSORPTION; BLOOD COMPONENT REMOVAL; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; HYPERLIPIDEMIAS; KIDNEY GLOMERULUS; LIPOPROTEINS, LDL; NEPHROTIC SYNDROME;

EID: 84900303875     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-013-0930-5     Document Type: Review

References (10)

1. Sulowicz W, Stompor T. LDL-apheresis and immunoadsorption: novel methods in the treatment of renal diseases refractory to conventional therapy. Nephrol Dial Transplant. 2003;18:v59-62. (Pubitemid 36896456)
2. Moorhead JF, Chan MK, El-Nahas M, et al. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet. 1982;2(8311):1309-11. (Pubitemid 13240921)
3. Ong AC, et al. Tubular lipidosis: epiphenomenon or pathogenetic lesion in human renal disease? Kidney Int. 1994;45:753-62. (Pubitemid 24094487)
4. Sakurai M, Muso E, Matsushima H, Ono T, Sasayama S. Rapid normalization of interleukin-8 production after low-density lipoprotein apheresis in steroid-resistant nephrotic syndrome. Kidney Int Suppl. 1999;71:S210-2. (Pubitemid 29304854)
5. Savin VJ, McCarthy ET, Sharma M. Permeability factors in focal segmental glomerulosclerosis. Semin Nephrol. 2003;23(2):147-60. (Pubitemid 36397097)
6. Dantal J, Bigot E, Bogers W, et al. Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med. 1994;330(1):7-14.
7. Miyata H, Uno K, Ono T, Yashiro M, Fukatsu A, Kita T, Kimura T, Muso E. Low density lipoprotein apheresis ameliorates interferon-γ production in patients with nephrotic syndrome. Ther Apher Dial. 2012;16(2):189-94.
8. Muso E, Mune M, Fujii Y, et al. Significantly rapid relief from steroid resistant nephrotic syndrome by LDL-apheresis compared with steroid monotherapy. Nephron. 2001;89(4):408-15. (Pubitemid 33135820)
9. Muso E, Mune M, Yorioka N, et al. Beneficial effect of low-density lipoprotein apheresis (LDL-A) on refractory nephrotic syndrome (NS) due to focal glomerulosclerois (FGS). Clin Nephrol. 2007;67(6):341-4. (Pubitemid 46894797)
10. Yokoyama H, et al. Jpn J Apheresis. 2006;25(1):31-7 (in Japanese).